Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano-X Imaging (NNOX) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for Nano-X Imaging (NNOX) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.

  • Nano-X Imaging's Capital Expenditures fell 13705.72% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 7290.71%. This contributed to the annual value of $2.8 million for FY2024, which is 1622.77% down from last year.
  • As of Q3 2025, Nano-X Imaging's Capital Expenditures stood at -$1.7 million, which was down 13705.72% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, Nano-X Imaging's Capital Expenditures registered a high of $40.4 million during Q4 2021, and its lowest value of -$6.7 million during Q2 2021.
  • Moreover, its 5-year median value for Capital Expenditures was -$936000.0 (2023), whereas its average is $1.7 million.
  • In the last 5 years, Nano-X Imaging's Capital Expenditures skyrocketed by 9056.86% in 2024 and then plummeted by 27375.89% in 2025.
  • Quarter analysis of 5 years shows Nano-X Imaging's Capital Expenditures stood at $40.4 million in 2021, then crashed by 63.97% to $14.6 million in 2022, then tumbled by 58.25% to $6.1 million in 2023, then dropped by 26.01% to $4.5 million in 2024, then crashed by 138.69% to -$1.7 million in 2025.
  • Its Capital Expenditures was -$1.7 million in Q3 2025, compared to -$1.1 million in Q2 2025 and -$527000.0 in Q1 2025.